Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Also, a slight trend of stronger disease progression related to MRI criteria was observed in the 4 mg/day group compared to patients treated with 0.3 mg/day diazoxide.

also in 4,078 other papers

Comment While a first exploratory pilot study indicated improvements under EPO treatment, especially in terms of motor functions [ 244 ], these results could not be reproduced in the reviewed Phase II trial, even though a positive trend was observed [ 246 ].

also in 11,005 other papers